The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down around 0.4% in early afternoon trade.

Reporting season continues and JP Morgan says many of the results do not justify the high price to earnings ratios of ASX200 companies.

Staples are up around 1%, followed by Real Estate around 0.3%. Telecommunication has been the biggest loser down 1.6% followed by Materials and Energy – both down around 1.1%.

Company News

Fortescue Ltd (ASX: FMG) has been trading down around 1.7% after unveiling FY24 results. Revenue grew 8%, and underlying earnings before costs was up 7%.

The company declared a final year dividend of 89 cents per share, and the FY24 full year dividend was a 13% increase year over year. This equates to a grossed-up dividend yield of around 6.8%.

Fortescue has been trading at around $18.32

Tabcorp (ASX:TAH) has been behind the eight ball and down more than 12% in early afternoon trade. FY24 results revealed revenue was down 3.9% year on year to $2.34 billion and its Earnings before costs fell 18.7% to $317.7 million.

The company also booked a $1.4 billion impairment for the year due to fewer people gambling smaller amounts.

Tabcorp has been trading around 50 cents.

EML Payments (ASX:EML) has been down more 5.5% on FY24 results.

The company achieved an 18% increase in revenue to $217 million and a 34% uptick in underlying earnings before costs to $49 million. The result did not meet investor’s expectations.

EML Payments has been trading at around 73 cents.

More From The Market Online
Market Close Graphic

ASX Market Close: Financials lead index higher | January 16, 2025

The ASX200 closed up 1.38% at 8,327 points. Unemployment ticked up to 4%, in line with…
Two cartoon mine workers looking out over a mining project.

Southern Cross Gold Consolidated’s January ‘IPO’ is all a bit confusing. Here’s what happened

Southern Cross Gold Consolidated will be ringing the bell on the ASX today at 3PM in Sydney, and while it is listed as
Medical project manager using a laptop

Dimerix signs up first patient for ‘highly significant’ paediatric clinical trial

Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3
Market Update Graphic

ASX Market Update: Index rises as unemployment meets expectations | January 16, 2025

The ASX200 has been up 1.35% at 8,325 points on reports of a slowdown in U.S.…